Zobrazeno 1 - 10
of 331
pro vyhledávání: '"Betty K, Hamilton"'
Publikováno v:
Oncology and Therapy, Vol 12, Iss 3, Pp 451-464 (2024)
Abstract Introduction Chronic graft-versus-host disease (GVHD) following hematopoietic stem cell transplantation (HSCT) is associated with poor health-related quality of life (HRQoL) and functional status. However, few studies have evaluated chronic
Externí odkaz:
https://doaj.org/article/da3c4b302a134786bc75471c80879a5d
Autor:
Joseph Pidala, Paul A Carpenter, Lynn Onstad, Steven Z Pavletic, Betty K Hamilton, George L Chen, Nosha Farhadfar, Marcie Hall, Stephanie J Lee
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0298026 (2024)
Chronic graft-versus-host disease (GVHD) is an immune-mediated disorder that causes significant late morbidity and mortality following allogeneic hematopoietic cell transplantation. The "Close Assessment and Testing for Chronic GVHD (CATCH)" study is
Externí odkaz:
https://doaj.org/article/0ced38d2ce7a4db196f394077f4d1b82
Autor:
Simona Pagliuca, Carmelo Gurnari, Colin Hercus, Sébastien Hergalant, Sanghee Hong, Adele Dhuyser, Maud D’Aveni, Alice Aarnink, Marie Thérèse Rubio, Pierre Feugier, Francesca Ferraro, Hetty E. Carraway, Ronald Sobecks, Betty K. Hamilton, Navneet S. Majhail, Valeria Visconte, Jaroslaw P. Maciejewski
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-12 (2023)
Abstract Graft-versus-leukemia (GvL) reactions are responsible for the effectiveness of allogeneic hematopoietic cell transplantation as a treatment modality for myeloid neoplasia, whereby donor T- effector cells recognize leukemia neoantigens. Howev
Externí odkaz:
https://doaj.org/article/8c1bcd077dcf4d8795e32c0ba12bd5cc
Autor:
Jingbo Yu, Betty K. Hamilton, James Turnbull, Susan K. Stewart, Alla Vernaya, Valkal Bhatt, Oren Meyers, John Galvin
Publikováno v:
Cancer Medicine, Vol 12, Iss 3, Pp 3623-3633 (2023)
Abstract Background Chronic graft‐versus‐host disease (GVHD) is a potentially life‐threatening complication of allogeneic hematopoietic stem cell transplantation (HSCT) treatment for hematologic malignancies. There are limited patient‐reporte
Externí odkaz:
https://doaj.org/article/6c7465fa181440c7bf989fdf0cc4bbf3
Autor:
Annie Im, Iskra Pusic, Lynn Onstad, Carrie L. Kitko, Betty K. Hamilton, Amin M. Alousi, Mary E. Flowers, Stefanie Sarantopoulos, Paul Carpenter, Jennifer White, Sally Arai, Najla El Jurdi, George Chen, Corey Cutler, Stephanie Lee, Joseph Pidala
Publikováno v:
Haematologica, Vol 109, Iss 1 (2023)
Chronic graft-versus-host disease (GvHD) treatment response is assessed using National Institutes of Health (NIH) Consensus Criteria in clinical trials, and by clinician assessment in routine practice. Patient-reported treatment response is central t
Externí odkaz:
https://doaj.org/article/283a5f6124c24e439b68155af4159bea
Autor:
George L. Chen, Lynn Onstad, Paul J. Martin, Paul Carpenter, Joseph Pidala, Sally Arai, Corey Cutler, Betty K. Hamilton, Stephanie J. Lee, Mukta Arora
Publikováno v:
Haematologica, Vol 108, Iss 2 (2022)
Successful treatment of chronic graft-versus-host disease (GvHD) often requires long-term systemic therapy (ST). Durable discontinuation of ST reflects the resolution of active chronic GvHD. We evaluated the factors associated with durable ST discont
Externí odkaz:
https://doaj.org/article/52ae3a7854544855a9a0420f7b3ffe75
Autor:
Matthew Mei, Raju Pillai, Soyoung Kim, Noel Estrada-Merly, Michelle Afkhami, Lixin Yang, Zhuo Meng, Muhammad Bilal Abid, Mahmoud Aljurf, Ulrike Bacher, Amer Beitinjaneh, Christopher Bredeson, Jean-Yves Cahn, Jan Cerny, Edward Copelan, Corey Cutler, Zachariah DeFilipp, Miguel Angel Diaz Perez, Nosha Farhadfar, César O. Freytes, Shahinaz M. Gadalla, Siddhartha Ganguly, Robert Peter Gale, Usama Gergis, Michael R. Grunwald, Betty K. Hamilton, Shahrukh Hashmi, Gerhard C. Hildebrandt, Hillard M. Lazarus, Mark Litzow, Reinhold Munker, Hemant S. Murthy, Sunita Nathan, Taiga Nishihori, Sagar S. Patel, David Rizzieri, Sachiko Seo, Mithun Vinod Shah, Melhem Solh, Leo F. Verdonck, Ravi Vij, Ronald M. Sobecks, Betul Oran, Bart L. Scott, Wael Saber, Ryotaro Nakamura
Publikováno v:
Haematologica, Vol 108, Iss 1 (2022)
Somatic mutations are recognized as an important prognostic factor in chronic myelomonocytic leukemia (CMML). However, limited data are available regarding their impact on outcomes after allogeneic hematopoietic cell transplantation (HCT). In this re
Externí odkaz:
https://doaj.org/article/23076c7290164061a98b071548e28beb
Autor:
Yoshihiro Inamoto, Stephanie J. Lee, Lynn E. Onstad, Mary E.D. Flowers, Betty K. Hamilton, Madan H. Jagasia, Paul J. Martin, Steven Z. Pavletic, Joseph A. Pidala, Iskra Pusic, Georgia B. Vogelsang, Daniel Wolff, Paul A. Carpenter
Publikováno v:
Blood Advances, Vol 4, Iss 1, Pp 40-46 (2020)
Abstract: Implementation of the 2014 National Institutes of Health (NIH) response algorithm for joint/fascia graft-versus-host disease (GVHD) has identified real-world limits to its application. To refine the 2014 NIH response algorithm, we analyzed
Externí odkaz:
https://doaj.org/article/7b061d43ccbe4b15999f4b8b96d6b960
Autor:
Caner Saygin, Ashwin Kishtagari, Ryan D. Cassaday, Natalie Reizine, Ilana Yurkiewicz, Michaela Liedtke, Wendy Stock, Richard A. Larson, Ross L. Levine, Martin S. Tallman, Jae H. Park, Cassandra Kerr, Bartlomiej Przychodzen, Mikkael A. Sekeres, Matt E. Kalaycio, Hetty E. Carraway, Betty K. Hamilton, Ronald Sobecks, Aaron Gerds, Sudipto Mukherjee, Aziz Nazha, Jaroslaw P. Maciejewski, Anjali S. Advani
Publikováno v:
Blood Advances, Vol 3, Iss 24, Pp 4228-4237 (2019)
Abstract: Patients with therapy-related acute lymphoblastic leukemia (t-ALL) represent a small subset of acute lymphoblastic leukemia (ALL) patients who received genotoxic therapy (ie, chemotherapy or radiation) for a prior malignancy. These patients
Externí odkaz:
https://doaj.org/article/cab86d84cd7c4e9c8f87db118e5bdbb6
Autor:
Simona Pagliuca, Carmelo Gurnari, Sanghee Hong, Ran Zhao, Sunisa Kongkiatkamon, Laila Terkawi, Misam Zawit, Yihong Guan, Hassan Awada, Ashwin Kishtagari, Cassandra M. Kerr, Thomas LaFramboise, Bhumika J. Patel, Babal K. Jha, Hetty E. Carraway, Valeria Visconte, Navneet S. Majhail, Betty K. Hamilton, Jaroslaw P. Maciejewski
Publikováno v:
JCI Insight, Vol 6, Iss 13 (2021)
TCR repertoire diversification constitutes a foundation for successful immune reconstitution after allogeneic hematopoietic cell transplantation (allo-HCT). Deep TCR Vβ sequencing of 135 serial specimens from a cohort of 35 allo-HCT recipients/donor
Externí odkaz:
https://doaj.org/article/720a398ed82f4d6bab113a63c1654381